Main area of scientific interests concerns hypertension aspects (risk stratification, prehypertension, new biomarkers, optimal level of BP - J-curve phenomenon, pharmacotherapy/combined therapy, prevention, complications), lipid disorders (risk stratification, new biomarkers, diagnosis, rare diseases), dyslipidemia therapy (statins, new drugs, combined treatment) and new drugs in CVD therapy.

Date Time Room Session/Title Presentation
Presentation Title Role
Sep. 12 (Sat) 10:40-12:20 Symposium 26
Novel Role of HDL – Clinical Perspectives
11:00-11:25 International Lipid Expert Panel (ILEP) 2020 Guidelines on the Definition and Management With Statin Intolerance Speaker